Sequoia Capital leads $50m Series C in Chinese biotech startup Adagene

Sequoia Capital leads $50m Series C in Chinese biotech startup Adagene

Photo: Pixabay

Mars W. Mosqueda Jr.

27 March, 2018

AdageneSequoia Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.